Speakers

* Speakers confirmed to-date. Please check back as new speakers are being added

Co-Chairs

Jason R. Parish

Shareholder
Buchanan Ingersoll & Rooney PC

A Question of Responsibility: Understanding the Impact of the MDL settlement

July 21, 2020 • 10:45 am

Richard S. Hartunian

Partner
Manatt, Phelps & Phillips, LLP

DEA Keynote on Federal Enforcement Initiatives

July 21, 2020 • 9:00 am

Government

Dominic Chiapperino, Ph.D.

Director, Controlled Substance Staff
Center for Drug Evaluation and Research
Food and Drug Administration

Controlled Substances Initiatives for Cannabis, Opioids and New Drug Research

July 22, 2020 • 12:45 pm

Gustav Eyler

Director, Consumer Protection Branch
U.S. Department of Justice

Recent DOJ Civil and Criminal Enforcement Efforts

July 22, 2020 • 10:10 am

Ross Goldstein

Senior Litigation Counsel
U.S. Department of Justice

The Enforcers Speak: State and Federal Enforcement Initiatives

July 22, 2020 • 11:45 am

Elliot M. Schachner

Assistant U.S Attorney, U.S. Attorney’s Office
Eastern District of New York

The Enforcers Speak: State and Federal Enforcement Initiatives

July 22, 2020 • 11:45 am

Claire M. Brennan

Section Chief, Liaison Section, Diversion Control Division
U.S. Drug Enforcement Administration

DEA Keynote on Federal Enforcement Initiatives

July 21, 2020 • 9:00 am

Scott A. Brinks

Section Chief Regulatory Drafting & Policy Support Section Diversion Control Division
U.S. Drug Enforcement Administration

DEA Keynote on Federal Enforcement Initiatives

July 21, 2020 • 9:00 am

In-House and Outside Counsel

Susan E. Briones

Partner
Lewis Brisbois

Recognizing Dangerous Patterns for New Drugs of Concern

July 22, 2020 • 3:00 pm

Ronald W. Chapman II

Shareholder
Chapman Law Group

Tailoring Inspection Strategies for Every Link of the Supply Chain

July 21, 2020 • 2:00 pm

Shannon F. Cox

Counsel
King & Spalding LLP

Tailoring Inspection Strategies for Every Link of the Supply Chain

July 21, 2020 • 2:00 pm

Hunter DeKoninck

Attorney
Quarles & Brady LLP

DEA Due Diligence for Manufacturers, Distributors and Pharmacists

July 22, 2020 • 3:30 pm

Delia A. Deschaine

Partner
Epstein Becker & Green P.C.

WORKSHOP A: Controlled Substances Bootcamp: An Introduction to Key Agencies, Regulation, and Scheduling

July 20, 2020 • 9:00 am

Tom Firestone

Partner
Baker & McKenzie LLP

WORKSHOP A: Controlled Substances Bootcamp: An Introduction to Key Agencies, Regulation, and Scheduling

July 20, 2020 • 9:00 am

Joseph Fortunak

Professor, Chemistry and Pharmaceutical Sciences
Howard University

Incentives for New Therapeutics to Treat Pain and Addiction

July 22, 2020 • 9:10 am

Ronald J. Friedman

Shareholder
Karr Tuttle Campbell

Recognizing Dangerous Patterns for New Drugs of Concern

July 22, 2020 • 3:00 pm

John A. Gilbert, Jr.

Director
Hyman, Phelps & McNamara PC

Adjusting Your Compliance Program in Light of Recent Developments

July 21, 2020 • 11:30 am

Todd H. Halpern

Assistant General Counsel, Legal Operations-MSC, Consumer Healthcare Quality, CMO and EHS
GSK

Tailoring Inspection Strategies for Every Link of the Supply Chain

July 21, 2020 • 2:00 pm

Todd A. Harrison

Partner
Venable LLP

Cannabis, Hemp and the Legal Status of Products Containing Cannabidiol (CBD)

July 22, 2020 • 2:30 pm

Derrelle M. Janey

Partner
Gottlieb & Janey LLP

A Question of Responsibility: Understanding the Impact of the MDL settlement

July 21, 2020 • 10:45 am

Shruti Kulkarni

Attorney
DCBA Law & Policy

A Question of Responsibility: Understanding the Impact of the MDL settlement

July 21, 2020 • 10:45 am

Seth A. Mailhot

Partner
Husch Blackwell

Incentives for New Therapeutics to Treat Pain and Addiction

July 22, 2020 • 9:10 am

Jennifer Razor

Managing Partner
Cirrina Legal

The Enforcers Speak: State and Federal Enforcement Initiatives

July 22, 2020 • 11:45 am

Kinsey S. Reagan

Partner
Kleinfeld Kaplan & Becker LLP

David Schiller

Former Assistant Special Agent in Charge, U.S. DEA
Presider & CEO and CoFounder
NarcX

Jur Strobos

Partner
Potomac Law Group

WORKSHOP A: Controlled Substances Bootcamp: An Introduction to Key Agencies, Regulation, and Scheduling

July 20, 2020 • 9:00 am

Kenneth A. Weinstein

Vice President
Analysis Group

Adjusting Your Compliance Program in Light of Recent Developments

July 21, 2020 • 11:30 am

Rebecca K. Wood

Partner
Sidley Austin LLP

Cannabis, Hemp and the Legal Status of Products Containing Cannabidiol (CBD)

July 22, 2020 • 2:30 pm

Will Woodlee

Partner
Kleinfeld Kaplan & Becker LLP

Cannabis, Hemp and the Legal Status of Products Containing Cannabidiol (CBD)

July 22, 2020 • 2:30 pm